Main Hall
12:30 – 13:30h
The aim of the panel is to show how new technologies are increasingly present in drug discovery processes and this presence varies depending on the type of company and its particular objectives. Therefore, the aim is for the guests to provide specific examples of the use of new technologies in the drug discovery process, providing case studies that highlight the use of these technologies.
Speakers

Jordi Mestres
CSO at Chemotargets

Olga Genilloud
Scientific Director at the Medina Foundation

Lászlo Kiss
Senior Manager, Medicinal Chemistry en BIAL

Juan José Carrillo
Director of the Department of Biophysics and Pharmacology at Lilly Spain
Moderated by:

Iván Marcos
Pharma/Biotech Strategic Collaborations Manager at Promega